Minnesota Partnership awards four collaborative research grants for 2024
ROCHESTER, Minn. — The Minnesota Partnership for Biotechnology and Medical Genomics (MNP) has announced…
CagriSema shows promise in Novo Nordisk’s phase 3 obesity trial
Bagsværd, Denmark- December 2024- Novo Nordisk announced headline results from REDEFINE 1,…
MoHAP launches National School Health Screening guideline
UAE- December 2024- The Ministry of Health and Prevention (MoHAP) UAE has…
Electro-Acupuncture: A surprising solution for weight loss?
Singapore- October 2024- A team of scientists led by Nanyang Technological University…
How cardiovascular disease affects women: myths, facts, and realities
Cardiovascular disease (CVD) is the leading cause of death for both men…
The Role of Precision Medicine in Personalized Nutrition
Precision medicine (PM) and precision nutrition seek to improve disease management. The…
MoHAP Signs Agreement with Novo Nordisk Pharma Gulf
The Ministry of Health and Prevention (MoHAP) has teamed up with Novo…
Lancet Study: Semaglutide Reduces Risk of CV Death and Worsening Heart Failure
PLAINSBORO, N.J- Recently, The Lancet published a new pooled, participant-level analysis of patients…
Could single-Dose Zepbound Vials be a game-changer for weight loss?
August 2024- Eli Lilly and Company announced Zepbound ® (tirzepatide) 2.5 mg…
MoHAP trains school health staff to combat childhood obesity
August 2024- The Ministry of Health and Prevention (MoHAP) has organized a…